These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30272672)

  • 1. Standardized Measurement of Nasal Membrane Transepithelial Potential Difference (NPD).
    Solomon GM; Bronsveld I; Hayes K; Wilschanski M; Melotti P; Rowe SM; Sermet-Gaudelus I
    J Vis Exp; 2018 Sep; (139):. PubMed ID: 30272672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening.
    Sermet-Gaudelus I; Roussel D; Bui S; Deneuville E; Huet F; Reix P; Bellon G; Lenoir G; Edelman A
    BMC Pediatr; 2006 Oct; 6():25. PubMed ID: 17018149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal potential difference in congenital bilateral absence of the vas deferens.
    Pradal U; Castellani C; Delmarco A; Mastella G
    Am J Respir Crit Care Med; 1998 Sep; 158(3):896-901. PubMed ID: 9731023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transepithelial nasal potential difference (NPD) measurements in cystic fibrosis (CF).
    Sands D
    Med Wieku Rozwoj; 2013; 17(1):13-7. PubMed ID: 23749691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of nasal potential difference and sweat chloride as outcome measures in multicenter clinical trials in subjects with cystic fibrosis.
    Ahrens RC; Standaert TA; Launspach J; Han SH; Teresi ME; Aitken ML; Kelley TJ; Hilliard KA; Milgram LJ; Konstan MW; Weatherly MR; McCarty NA
    Pediatr Pulmonol; 2002 Feb; 33(2):142-50. PubMed ID: 11802252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of nasal potential difference in young children with an equivocal sweat test following newborn screening for cystic fibrosis.
    Sermet-Gaudelus I; Girodon E; Roussel D; Deneuville E; Bui S; Huet F; Guillot M; Aboutaam R; Renouil M; Munck A; des Georges M; Iron A; Thauvin-Robinet C; Fajac I; Lenoir G; Roussey M; Edelman A
    Thorax; 2010 Jun; 65(6):539-44. PubMed ID: 20522854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind, placebo controlled, dose ranging study to evaluate the safety and biological efficacy of the lipid-DNA complex GR213487B in the nasal epithelium of adult patients with cystic fibrosis.
    Knowles MR; Noone PG; Hohneker K; Johnson LG; Boucher RC; Efthimiou J; Crawford C; Brown R; Schwartzbach C; Pearlman R
    Hum Gene Ther; 1998 Jan; 9(2):249-69. PubMed ID: 9472784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does integration of various ion channel measurements improve diagnostic performance in cystic fibrosis?
    Ooi CY; Dupuis A; Gonska T; Ellis L; Ni A; Jarvi K; Martin S; Ray P; Steele L; Kortan P; Dorfman R; Solomon M; Zielenski J; Corey M; Tullis E; Durie P
    Ann Am Thorac Soc; 2014 May; 11(4):562-70. PubMed ID: 24697796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic fibrosis in 65- and 67-year-old siblings. Clinical feature and nasal potential difference measurement in patients with genotypes F508del and 2789+5G-->A.
    Mainz J; Hammer U; Rokahr C; Hubler A; Zintl F; Ballmann M
    Respiration; 2006; 73(5):698-704. PubMed ID: 16763370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis.
    Knowles MR; Paradiso AM; Boucher RC
    Hum Gene Ther; 1995 Apr; 6(4):445-55. PubMed ID: 7542031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into the variability of nasal potential difference, a biomarker of CFTR activity.
    Kyrilli S; Henry T; Wilschanski M; Fajac I; Davies JC; Jais JP; Sermet-Gaudelus I
    J Cyst Fibros; 2020 Jul; 19(4):620-626. PubMed ID: 31699569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Na+ and Cl- conductances in airway epithelial cells: increased Na+ conductance in cystic fibrosis.
    Kunzelmann K; Kathöfer S; Greger R
    Pflugers Arch; 1995 Nov; 431(1):1-9. PubMed ID: 8584404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal potential difference measurements to assess CFTR ion channel activity.
    Rowe SM; Clancy JP; Wilschanski M
    Methods Mol Biol; 2011; 741():69-86. PubMed ID: 21594779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasal potential difference outcomes support diagnostic decisions in cystic fibrosis.
    Tridello G; Menin L; Pintani E; Bergamini G; Assael BM; Melotti P
    J Cyst Fibros; 2016 Sep; 15(5):579-82. PubMed ID: 27423539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide has no beneficial effects on ion transport defects in cystic fibrosis human nasal epithelium.
    Rückes-Nilges C; Lindemann H; Klimek T; Glanz H; Weber WM
    Pflugers Arch; 2000 Nov; 441(1):133-7. PubMed ID: 11205052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of rhinovirus infection on the expression and function of cystic fibrosis transmembrane conductance regulator and epithelial sodium channel in human nasal mucosa.
    Kim JH; Kwon HJ; Jang YJ
    Ann Allergy Asthma Immunol; 2012 Mar; 108(3):182-7. PubMed ID: 22374202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chloride transport in nasal ciliated cells of cystic fibrosis heterozygotes.
    Sermet-Gaudelus I; Déchaux M; Vallée B; Fajac A; Girodon E; Nguyen-Khoa T; Marianovski R; Hurbain I; Bresson JL; Lenoir G; Edelman A
    Am J Respir Crit Care Med; 2005 May; 171(9):1026-31. PubMed ID: 15709055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol ameliorates abnormalities of fluid and electrolyte secretion in a hypoxia-Induced model of acquired CFTR deficiency.
    Woodworth BA
    Laryngoscope; 2015 Oct; 125 Suppl 7(0 7):S1-S13. PubMed ID: 25946147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protocols for in vivo measurement of the ion transport defects in cystic fibrosis nasal epithelium.
    Middleton PG; Geddes DM; Alton EW
    Eur Respir J; 1994 Nov; 7(11):2050-6. PubMed ID: 7875281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasal potential measurements on the nasal floor and under the inferior turbinate: does it matter?
    Vermeulen F; Proesmans M; Feyaerts N; De Boeck K
    Pediatr Pulmonol; 2011 Feb; 46(2):145-52. PubMed ID: 20865746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.